{"id":"https://openalex.org/W2590615916","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","title":"Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC): Final quality-of-life (QOL) results with safety data from the United Kingdom (UK) Early Access Programme (EAP) (NCT01254279).","display_name":"Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC): Final quality-of-life (QOL) results with safety data from the United Kingdom (UK) Early Access Programme (EAP) (NCT01254279).","publication_year":2013,"publication_date":"2013-02-20","ids":{"openalex":"https://openalex.org/W2590615916","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","mag":"2590615916"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.6_suppl.91","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034586479","display_name":"Amit K. Bahl","orcid":"https://orcid.org/0000-0002-8525-0310","observed_orcids":["https://orcid.org/0000-0002-8525-0310"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amit Bahl","raw_affiliation_strings":["Bristol Haematology and Oncology Centre, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Haematology and Oncology Centre, Bristol, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053173599","display_name":"Susan Masson","orcid":"https://orcid.org/0000-0001-7747-0412","observed_orcids":["https://orcid.org/0000-0001-7747-0412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Masson","raw_affiliation_strings":["Bristol Haematology and Oncology Centre, Bristol, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Haematology and Oncology Centre, Bristol, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109428428","display_name":"Zafar Malik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I283776267","display_name":"Clatterbridge Cancer Centre NHS Foundation Trust","ror":"https://ror.org/05gcq4j10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I283776267"]},{"id":"https://openalex.org/I4210104878","display_name":"Clatterbridge Hospital","ror":"https://ror.org/01dqhdd78","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104878","https://openalex.org/I4210163040"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zafar I. Malik","raw_affiliation_strings":["Clatterbridge Centre for Oncology, Wirral, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clatterbridge Centre for Oncology, Wirral, United Kingdom","institution_ids":["https://openalex.org/I283776267","https://openalex.org/I4210104878"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079820994","display_name":"Alison Jane Birtle","orcid":"https://orcid.org/0000-0002-2621-0909","observed_orcids":["https://orcid.org/0000-0002-2621-0909"]},"institutions":[{"id":"https://openalex.org/I1293129422","display_name":"Lancashire Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/02j7n9748","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alison J. Birtle","raw_affiliation_strings":["Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom","institution_ids":["https://openalex.org/I1293129422"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079843750","display_name":"Santhanam Sundar","orcid":"https://orcid.org/0000-0003-0850-5161","observed_orcids":["https://orcid.org/0000-0003-0850-5161"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Santhanam Sundar","raw_affiliation_strings":["Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048796030","display_name":"Robert J. Jones","orcid":"https://orcid.org/0000-0002-2904-6980","observed_orcids":["https://orcid.org/0000-0002-2904-6980","https://orcid.org/0000-0003-0759-8968"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert J. Jones","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022378006","display_name":"Nicholas David James","orcid":"https://orcid.org/0000-0002-7314-8204","observed_orcids":["https://orcid.org/0000-0002-7314-8204"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas David James","raw_affiliation_strings":["University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032518609","display_name":"Malcolm David Mason","orcid":"https://orcid.org/0000-0003-1505-2869","observed_orcids":["https://orcid.org/0000-0003-1505-2869"]},"institutions":[{"id":"https://openalex.org/I4210150388","display_name":"Velindre Cancer Centre","ror":"https://ror.org/049sr1d03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799279586","https://openalex.org/I4210150388"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malcolm David Mason","raw_affiliation_strings":["Velindre Cancer Centre, Cardiff, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Velindre Cancer Centre, Cardiff, United Kingdom","institution_ids":["https://openalex.org/I4210150388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048070921","display_name":"David Bottomley","orcid":"https://orcid.org/0000-0003-3948-5490","observed_orcids":["https://orcid.org/0000-0003-3948-5490"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Bottomley","raw_affiliation_strings":["St. James's Hospital, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. James's Hospital, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036443989","display_name":"Anna Lydon","orcid":"https://orcid.org/0000-0002-2048-7069","observed_orcids":["https://orcid.org/0000-0002-2048-7069"]},"institutions":[{"id":"https://openalex.org/I4210153833","display_name":"Torbay and South Devon NHS Foundation Trust","ror":"https://ror.org/05374b979","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210153833"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Lydon","raw_affiliation_strings":["South Devon Healthcare NHS Foundation Trust, Torquay, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Devon Healthcare NHS Foundation Trust, Torquay, United Kingdom","institution_ids":["https://openalex.org/I4210153833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110735930","display_name":"Simon Chowdhury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Chowdhury","raw_affiliation_strings":["Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108106258","display_name":"James Pinson Wylie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Wylie","raw_affiliation_strings":["The Christie NHS Foundation Trust, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Christie NHS Foundation Trust, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210133995"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann Sebastian De Bono","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"6_suppl","first_page":"91","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabazitaxel","display_name":"cabazitaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pain","display_name":"pain","score":0.453000009059906},{"id":"https://openalex.org/keywords/eq-5d","display_name":"EQ-5D","score":0.7950000166893005},{"id":"https://openalex.org/keywords/visual-analog-scale","display_name":"visual analogue scale","score":0.7749999761581421},{"id":"https://openalex.org/keywords/early-access-program","display_name":"early access program","score":0.6890000104904175},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.640999972820282},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5600000023841858},{"id":"https://openalex.org/keywords/neutropenic-sepsis","display_name":"neutropenic sepsis","score":0.8640000224113464},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8859999775886536},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.9664851427078247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9112774133682251},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.6715008616447449},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.622340738773346},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6025529503822327},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5805206298828125},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.5761784911155701},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5733585953712463},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.49339380860328674},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.4742949306964874},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.46891865134239197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.420332133769989},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.30186325311660767},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28633272647857666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22754156589508057},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.2160550057888031},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14674779772758484},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.09394949674606323},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.6_suppl.91","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.91","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1915734320","https://openalex.org/W4250978370","https://openalex.org/W2559806461","https://openalex.org/W2613734281","https://openalex.org/W3005467664","https://openalex.org/W2599939991","https://openalex.org/W2010594504","https://openalex.org/W2600932175","https://openalex.org/W2885183647","https://openalex.org/W2968566719"],"abstract_inverted_index":{"91":[0],"Background:":[1],"Several":[2],"drugs":[3],"can":[4],"now":[5],"improve":[6],"survival":[7,23],"in":[8,54,133,165,222,243,262],"mCRPC":[9,263],"after":[10],"docetaxel,":[11],"including":[12],"cabazitaxel,":[13],"a":[14,60],"next":[15],"generation":[16],"taxane.":[17],"TROPIC":[18],"(NCT00417079)":[19],"showed":[20],"an":[21,128],"overall":[22,129],"benefit":[24,259],"of":[25,167,174,215,246],"2.4":[26],"months":[27],"for":[28,33,276],"cabazitaxel":[29,80,261],"compared":[30],"with":[31,85,127,229,260],"mitoxantrone":[32],"mCRPC.":[34],"The":[35,250],"UK":[36,224,251],"EAP":[37,252],"provided":[38],"patients":[39,74,134,168,180,216,247],"access":[40],"to":[41,119,231],"cabazitaxel;":[42],"detailed":[43],"QOL":[44,67,124,226,258],"and":[45,59,68,92,106,121,158,201,234,266],"safety":[46,62,70,271],"data":[47,256,272],"were":[48,99,161,177,191],"recorded.":[49],"Interim":[50],"analysis":[51],"suggested":[52],"improvements":[53],"QOL,":[55],"particularly":[56],"pain":[57,147,159,240],"scores":[58,160],"good":[61],"profile.":[63],"We":[64],"report":[65],"final":[66],"updated":[69],"data.":[71],"Methods:":[72],"108":[73],"recruited":[75],"at":[76,101,103,107,154,162,169],"12":[77],"centres":[78],"received":[79,182,206],"25mg/m2intravenously":[81],"every":[82],"3":[83],"weeks":[84],"oral":[86],"prednisolone":[87],"10mg":[88],"daily.":[89],"EQ-5D":[90,120,233],"questionnaires":[91],"health":[93],"state":[94],"visual":[95],"analogue":[96],"scale":[97],"(VAS)":[98],"completed":[100,217],"baseline,":[102],"alternate":[104],"cycles":[105,176,221],"30":[108],"days":[109],"post":[110,264],"treatment.":[111,137],"Safety":[112],"assessments":[113],"followed":[114],"each":[115],"cycle.":[116],"Results:":[117],"According":[118],"VAS":[122,235],"scores,":[123],"was":[125,148,227,241],"stable":[126,164,228,239],"trend":[130],"towards":[131],"improvement":[132],"who":[135],"continued":[136],"Paired":[138],"\u2018within":[139],"patient\u2019":[140],"analyses":[141],"also":[142],"support":[143],"this":[144],"trend.":[145],"Improved":[146,237],"noted":[149],"more":[150,185,220],"frequently":[151],"than":[152],"deterioration":[153],"all":[155],"time":[156],"points":[157],"least":[163],"96%":[166],"cycle":[170],"10.":[171],"A":[172],"median":[173],"6":[175],"given.":[178],"34":[179],"(31%)":[181],"10":[183,218],"or":[184,219,238],"cycles.":[186],"Grade":[187],"3/4":[188],"adverse":[189],"events":[190],"uncommon,":[192],"the":[193,223,244,254],"most":[194],"frequent":[195],"being":[196],"fatigue":[197],"(9.3%),":[198],"diarrhoea":[199],"(2.8%)":[200],"neutropenic":[202],"sepsis":[203],"(1.9%).":[204],"85%":[205],"prophylactic":[207],"granulocyte":[208],"colony":[209],"stimulating":[210],"factor.":[211],"Conclusions:":[212],"Almost":[213],"1/3":[214],"EAP.":[225],"trends":[230],"improved":[232],"scores.":[236],"observed":[242],"majority":[245],"continuing":[248],"therapy.":[249],"provides":[253],"first":[255],"on":[257],"docetaxel":[265],"demonstrates":[267],"manageable":[268],"toxicity.":[269],"Final":[270],"will":[273],"be":[274],"available":[275],"presentation.":[277],"Clinical":[278],"trial":[279],"information:":[280],"NCT01254279.":[281],"[Table:":[282],"see":[283],"text]":[284]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-03-03T00:00:00"}
